Skip to content

Advanced liver imaging in Gaucher Disease: a pilot study

Advanced liver imaging in Gaucher Disease: a pilot study - Liver imaging in Gaucher Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34763
Enrollment
21
Registered
2010-03-04
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gaucher Disease lysosomal storage disorder

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with Gaucher Disease; Over 18 years of age; BMI under 27 kg/m2; At least 2 years of therapy; Written informed consent

Exclusion criteria

Exclusion criteria: Known history of chronic liver disease other than caused by Gaucher Disease; Alcohol more than 3 units per day for males and more than 2 units per day for females; Contra-indications for MRI scanning (standard checklist); younger than 18 years of age; use of medications that are known to affect the liver (see protocol)

Design outcomes

Secondary

MeasureTime frame
The differences between Gaucher Disease patients with high risk versus normal risk and Gaucher Disease patients versus healthy volunteers in: The spectrum of glucosylceramide in the liver obtained with 1H-MR Spectroscopy.

Primary

MeasureTime frame
The differences between Gaucher Disease patients with high risk versus normal risk and Gaucher Disease patients versus healthy volunteers in: -Elasticity measurements of the liver obtained with MR Elastography and FibroScan -Iron accumulation in the liver assessed by MRI and biochemical values.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)